Menarini International Operations Luxembourg SA clinical trials

A country office of Menarini Group

The registry lists 8 studies whose lead sponsor is Menarini International Operations Luxembourg SA. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 24, 2025.

Studies

Recruiting first, then most recently updated. Showing 8 of 8. All Menarini Group studies →

• Open-label inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtientsCompletedNCT06104423Phase 4

  Sponsor listed in the registry: Menarini International Operations Luxembourg SA

• Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each MonotherapyCompletedNCT05513937Phase 4

  Sponsor listed in the registry: Menarini International Operations Luxembourg SA

• Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back PainCompletedNCT05170841Phase 4

  Sponsor listed in the registry: Menarini International Operations Luxembourg SA

• Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each MonotherapyCompletedNCT05279807Phase 4

  Sponsor listed in the registry: Menarini International Operations Luxembourg SA

• Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each MonotherapyCompletedNCT05257148Phase 4

  Sponsor listed in the registry: Menarini International Operations Luxembourg SA

• Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and AsthmaCompletedNCT02761252Phase 4

  Sponsor listed in the registry: Menarini International Operations Luxembourg SA

• Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With GoutCompletedNCT02500641Phase 4

  Sponsor listed in the registry: Menarini International Operations Luxembourg SA

• Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or UrticariaCompletedNCT02576041Phase 4

  Sponsor listed in the registry: Menarini International Operations Luxembourg SA